CNBX Pharmaceuticals Inc. (CNBX) Long-Term Investments (2018 - 2022)

CNBX Pharmaceuticals (CNBX) has 5 years of Long-Term Investments data on file, last reported at $116217.0 in Q4 2022.

• Quarterly Long-Term Investments fell 79.39% year-over-year to $116217.0 in Q4 2022, while the trailing twelve-month figure through Nov 2022 was $116217.0 (down 79.39% YoY) and the FY2022 annual result came in at $176087.0, down 79.17% from the prior year.
• Long-Term Investments retreated to $116217.0 in Q4 2022, from $176087.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $9.2 million in Q2 2019 to a low of $116217.0 in Q4 2022.
• A 5-year average of $2.3 million and a median of $717470.0 in 2018 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2019 — Long-Term Investments surged 919.28% — and 2020, when it tumbled 95.14%.
• Tracing CNBX's Long-Term Investments over 5 years: stood at $1.0 million in 2018, then surged by 140.6% to $2.5 million in 2019, then grew by 23.1% to $3.0 million in 2020, then slumped by 81.38% to $564007.0 in 2021, then sank by 79.39% to $116217.0 in 2022.
• The last three Long-Term Investments figures came in at $116217.0 (Q4 2022), $176087.0 (Q3 2022), and $239478.0 (Q2 2022), per Business Quant data.